UTHR · Categories · Form 4

UTHR - SEC Form 4 insider transactions

United Therapeutics Corporation (UTHR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for UTHR

• 2d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,190,128 worth of shares (9,500 units at $546.33) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 2d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,462,824 worth of shares (10,000 units at $546.28) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 3d
  EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,540,642 worth of shares (8,300 units at $547.07) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 3d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,202,271 worth of shares (9,500 units at $547.61) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 4d
  Chairperson & CEO Rothblatt Martine A sold $5,114,742 worth of shares (9,500 units at $538.39) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 5d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,205,105 worth of shares (9,500 units at $547.91) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 5d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,478,663 worth of shares (10,000 units at $547.87) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 5d
  Amendment: Chairperson & CEO Rothblatt Martine A sold $863,947 worth of shares (1,500 units at $575.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 43,153 units (SEC Form 4)

  4/A - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 6d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,261,365 worth of shares (9,500 units at $553.83) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 9d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,656,298 worth of shares (10,000 units at $565.63) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 9d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,373,592 worth of shares (9,500 units at $565.64) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 10d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,466,283 worth of shares (9,500 units at $575.40) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 11d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,729,359 worth of shares (10,000 units at $572.94) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 12d
  Chairperson & CEO Rothblatt Martine A gifted 9,009 units of Common Stock and gifted 2,060 shares (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 12d
  Chairperson & CEO Rothblatt Martine A sold $5,393,558 worth of shares (9,500 units at $567.74) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 16d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $117.76 and sold $5,641,130 worth of shares (10,000 units at $564.11) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 16d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,359,011 worth of shares (9,500 units at $564.11) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 17d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,376,814 worth of shares (9,500 units at $565.98) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 17d
  EVP & GENERAL COUNSEL Mahon Paul A sold $4,671,399 worth of shares (8,300 units at $562.82) as part of a pre-agreed trading plan and exercised 8,300 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 18d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,395,399 worth of shares (9,500 units at $567.94) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 19d
  CFO AND TREASURER Edgemond James sold $5,673,098 worth of shares (10,000 units at $567.31) as part of a pre-agreed trading plan and exercised 10,000 shares at a strike of $122.17 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 19d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,386,857 worth of shares (9,500 units at $567.04) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 20d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,397,077 worth of shares (9,500 units at $568.11) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 23d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,457,566 worth of shares (9,500 units at $574.48) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 23d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $135.42 and sold $5,744,746 worth of shares (10,000 units at $574.47) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 24d
  SEC Form 4 filed by PRESIDENT AND COO Benkowitz Michael

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 24d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,497,166 worth of shares (9,500 units at $578.65) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 25d
  Chairperson & CEO Rothblatt Martine A sold $5,494,563 worth of shares (9,500 units at $578.38) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 25d
  Director Mesa Nilda sold $150,139 worth of shares (258 units at $581.93), decreasing direct ownership by 5% to 5,028 units (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 26d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,444,417 worth of shares (9,500 units at $573.10) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 26d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $135.42 and sold $5,730,317 worth of shares (10,000 units at $573.03) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 27d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,367,044 worth of shares (9,500 units at $564.95) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 27d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $135.42 and sold $5,785,775 worth of shares (10,000 units at $578.58) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 27d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,496,084 worth of shares (9,500 units at $578.54) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 31d
  EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,870,054 worth of shares (8,300 units at $586.75) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 31d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,600,468 worth of shares (9,500 units at $589.52) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 32d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,474,240 worth of shares (9,500 units at $576.24) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 33d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,481,232 worth of shares (9,500 units at $576.97) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 33d
  CFO AND TREASURER Edgemond James sold $5,769,338 worth of shares (10,000 units at $576.93) as part of a pre-agreed trading plan and exercised 10,000 shares at a strike of $135.42 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 34d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,420,472 worth of shares (9,500 units at $570.58) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 37d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,439,991 worth of shares (9,500 units at $572.63) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 37d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $135.42 and sold $5,726,062 worth of shares (10,000 units at $572.61) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 38d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,426,598 worth of shares (9,500 units at $571.22) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 39d
  Chairperson & CEO Rothblatt Martine A sold $5,396,353 worth of shares (9,500 units at $568.04) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 40d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,403,684 worth of shares (9,500 units at $568.81) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 40d
  CFO AND TREASURER Edgemond James sold $5,688,319 worth of shares (10,000 units at $568.83) as part of a pre-agreed trading plan and exercised 10,000 shares at a strike of $135.42 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 41d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,365,678 worth of shares (9,500 units at $564.81) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 44d
  CFO AND TREASURER Edgemond James exercised 10,000 shares at a strike of $135.42 and sold $5,723,438 worth of shares (10,000 units at $572.34) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 44d
  Chairperson & CEO Rothblatt Martine A sold $5,437,340 worth of shares (9,500 units at $572.35) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $146.03 (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 44d
  Director Patusky Christopher exercised 2,910 shares at a strike of $101.80 and sold $1,655,790 worth of shares (2,910 units at $569.00) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 45d
  Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,477,366 worth of shares (9,500 units at $576.56) as part of a pre-agreed trading plan (SEC Form 4)

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 46d
  SEC Form 4 filed by Rothblatt Martine A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 47d
  SEC Form 4 filed by Rothblatt Martine A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 47d
  SEC Form 4 filed by Edgemond James

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 48d
  SEC Form 4 filed by Rothblatt Martine A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 51d
  SEC Form 4 filed by Patusky Christopher

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 51d
  SEC Form 4 filed by Rothblatt Martine A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 51d
  SEC Form 4 filed by Edgemond James

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 52d
  SEC Form 4 filed by Rothblatt Martine A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
• 52d
  SEC Form 4 filed by Mahon Paul A

  4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)

Other UTHR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends